News
In 502 patients with end-stage kidney disease (ESKD) receiving hemodialysis via AVG, time to a graft thrombosis event was not significantly different for those on 6 mg of MK-2060 (HR 0.83, 95% CI ...
There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback